Improving Molecular Testing and Personalized Medicine in Non-Small-Cell Lung Cancer in Ontario

Current Oncology - Canada
doi 10.3747/co.24.3495
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

MultiMed Inc.

Related search

P1.01-043 Molecular Testing for Non-Small Cell Lung Cancer in Latin American

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine

Frontiers in Oncology
Cancer ResearchOncology
2017English

The Role of Cytology in Molecular Testing and Personalized Medicine in Lung Cancer: A Clinical Perspective

Cancer cytopathology
Cancer ResearchOncology
2018English

How Does Health Technology Assessment of Personalized Medicine for Non-Small Cell Lung Cancer Differ in France, Germany, and England?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Personalized Medicine Tackles Clinical Resistance: Alectinib in ALK-Positive Non-Small Cell Lung Cancer Progressing on First-Generation ALK Inhibitor

Clinical Cancer Research
Cancer ResearchOncology
2016English

Improving Radiation Therapy for Non-Small Cell Lung Cancer: Molecular Imaging and a Team-Based Approach

Biomedical Imaging and Intervention Journal
2007English

Molecular Gene Signature and Prognosis of Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Biomarker Testing in Non-Small Cell Lung Cancer: To Move Forward With Quality

Clinical and Translational Oncology
MedicineCancer ResearchOncology
2012English

Non-Small Cell Lung Cancer

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy